Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Operating Expenses: 2020-2025

Historic Operating Expenses for iSpecimen (ISPC) over the last 6 years, with Sep 2025 value amounting to $2.9 million.

  • iSpecimen's Operating Expenses fell 32.76% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year decrease of 23.16%. This contributed to the annual value of $22.0 million for FY2024, which is 4.37% up from last year.
  • Latest data reveals that iSpecimen reported Operating Expenses of $2.9 million as of Q3 2025, which was up 15.87% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, iSpecimen's Operating Expenses registered a high of $7.3 million during Q4 2024, and its lowest value of $2.5 million during Q2 2025.
  • Over the past 3 years, iSpecimen's median Operating Expenses value was $5.0 million (recorded in 2024), while the average stood at $4.7 million.
  • As far as peak fluctuations go, iSpecimen's Operating Expenses surged by 105.62% in 2021, and later slumped by 49.76% in 2025.
  • Quarterly analysis of 5 years shows iSpecimen's Operating Expenses stood at $4.5 million in 2021, then grew by 12.30% to $5.1 million in 2022, then grew by 6.72% to $5.4 million in 2023, then spiked by 34.33% to $7.3 million in 2024, then tumbled by 32.76% to $2.9 million in 2025.
  • Its Operating Expenses was $2.9 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.7 million in Q1 2025.